Mid Atlantic Financial Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$2.32M Buy
18,514
+56
+0.3% +$7.25K 0.16% 132
2021
Q2
$2.29M Buy
18,458
+1,083
+6% +$136K 0.15% 134
2021
Q1
$2.05M Buy
17,375
+249
+1% +$29.2K 0.15% 136
2020
Q4
$2.01M Buy
17,126
+542
+3% +$59.7K 0.15% 136
2020
Q3
$1.88M Sell
16,584
-1,043
-6% -$105K 0.16% 125
2020
Q2
$1.62M Sell
17,627
-4,468
-20% -$428K 0.16% 126
2020
Q1
$1.99M Buy
22,095
+5,872
+36% +$625K 0.23% 94
2019
Q4
$1.84M Buy
16,223
+360
+2% +$39.5K 0.17% 123
2019
Q3
$1.72M Sell
15,863
-3,546
-18% -$370K 0.18% 109
2019
Q2
$1.89M Sell
19,409
-1,151
-6% -$105K 0.2% 108
2019
Q1
$1.87M Buy
20,560
+165
+0.8% +$14.8K 0.2% 101
2018
Q4
$1.85M Buy
+20,395
New +$1.91M 0.23% 97

Other funds holding MDT

Mid Atlantic Financial Management's MDT Position: Q3 2021 in Review

Mid Atlantic Financial Management increased its Medtronic (MDT) stake by 0.3% in Q3 2021, buying an estimated $7.25K and bringing the position to 18,514 shares worth $2.32M. The position accounts for 0.16% of the portfolio, ranked #132.

Mid Atlantic Financial Management first reported a position in MDT in Q4 2018 and has held it in 12 quarters since. 2,023 funds tracked by Wall St. Rank hold MDT as of Q3 2021.

  • Mid Atlantic Financial Management held 18,514 shares of Medtronic worth $2.32M as of Q3 2021.
  • Mid Atlantic Financial Management bought 56 Medtronic shares in Q3 2021, an estimated $7.25K.
  • Medtronic made up 0.16% of Mid Atlantic Financial Management's portfolio in Q3 2021, its #132 holding.
  • Mid Atlantic Financial Management first reported a position in Medtronic in Q4 2018 and has held it in 12 quarters since.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.